eloralintide vs retatrutide Weight Loss: How Much At Each Dose - On The Pen GLP-1 News Experimental Obesity Drug Eloralintide Helped

Learn why this GLP-1 medication causes bloating, how common it is, and discover proven strategies to manage digestive side effects while taking Ozempic, Wegovy, or Rybelsus.

Novo Nordisk CEO Mike Doustdar told Jim Cramer about developments in obesity treatment.

So far, so good!

But as our clinical practice continues to reveal, many people experience a troubling shift toward constipation or slowed motility after starting these medications

Interesting paper by Viral NShah, Tadej Battelino, Moshe Phillip and Rich Bergenstal

Its a man-made peptide developed by Eli Lilly and Company, and it works by acting on three hormones in the body: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon